Babesia microti infection in a patient with multiple sclerosis treated with ocrelizumab
- 2 January 2021
- journal article
- letter
- Published by Elsevier BV in Multiple Sclerosis and Related Disorders
- Vol. 48, 102731
- https://doi.org/10.1016/j.msard.2020.102731
Abstract
No abstract availableKeywords
Funding Information
- University of Connecticut
This publication has 29 references indexed in Scilit:
- Staying alive: regulation of plasma cell survivalTrends in Immunology, 2011
- Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory TherapiesAnnual Review of Medicine, 2010
- Babesiosis: Recent insights into an ancient diseaseInternational Journal for Parasitology, 2008
- Persistent and Relapsing Babesiosis in Immunocompromised PatientsClinical Infectious Diseases, 2008
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabThe New England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisThe New England Journal of Medicine, 2005
- Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challengeLeukemia, 2002
- Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patientsCancer, 2001
- Babesiosis in Patients with AIDS: A Chronic Infection Presenting as Fever of Unknown OriginClinical Infectious Diseases, 1996
- The Emergence of Lyme Disease and Human Babesiosis in a Changing EnvironmentaAnnals of the New York Academy of Sciences, 1994